相似文献
1
Collaborative effects between the TNFα-TNFR1-macrophage axis and the VEGF-C-VEGFR3 signaling in lymphangiogenesis and metastasis.
Oncoimmunology. 2015 Jan 22;4(3):e989777. doi: 10.4161/2162402X.2014.989777. eCollection 2015 Mar.
2
TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling.
Nat Commun. 2014 Sep 17;5:4944. doi: 10.1038/ncomms5944.
3
Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3.
Cells. 2019 Mar 21;8(3):270. doi: 10.3390/cells8030270.
4
Induction of lymphangiogenesis through vascular endothelial growth factor-C/vascular endothelial growth factor receptor 3 axis and its correlation with lymph node metastasis in nasopharyngeal carcinoma.
Oral Oncol. 2012 Aug;48(8):703-8. doi: 10.1016/j.oraloncology.2012.02.003. Epub 2012 Feb 25.
5
TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway.
BMC Cancer. 2016 Mar 19;16:240. doi: 10.1186/s12885-016-2259-4.
6
Pathway-related molecules of VEGFC/D-VEGFR3/NRP2 axis in tumor lymphangiogenesis and lymphatic metastasis.
Clin Chim Acta. 2016 Oct 1;461:165-71. doi: 10.1016/j.cca.2016.08.008. Epub 2016 Aug 12.
7
Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
BMC Cancer. 2018 Jul 6;18(1):718. doi: 10.1186/s12885-018-4619-8.
8
The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
J Dermatol Sci. 2014 Feb;73(2):135-41. doi: 10.1016/j.jdermsci.2013.10.006. Epub 2013 Oct 29.
9
Molecular controls of lymphatic VEGFR3 signaling.
Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):421-9. doi: 10.1161/ATVBAHA.114.304881. Epub 2014 Dec 18.
10
VEGF-C-VEGFR3/Flt4 axis regulates mammary tumor growth and metastasis in an autocrine manner.
Am J Cancer Res. 2015 Jan 15;5(2):616-28. eCollection 2015.
引用本文的文献
1
NAT10 Promotes Gastric Cancer Liver Metastasis by Modulation of M2 Macrophage Polarization and Metastatic Tumor Cell Hepatic Adhesion.
Adv Sci (Weinh). 2025 Apr;12(15):e2410263. doi: 10.1002/advs.202410263. Epub 2025 Feb 22.
2
Crosstalk Between Macrophages and Breast Cancer Cells: Networking Within Tumors.
Results Probl Cell Differ. 2024;74:213-238. doi: 10.1007/978-3-031-65944-7_8.
3
Immunocytes interact directly with cancer cells in the tumor microenvironment: one coin with two sides and future perspectives.
Front Immunol. 2024 May 22;15:1388176. doi: 10.3389/fimmu.2024.1388176. eCollection 2024.
4
Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review).
Int J Oncol. 2024 Jun;64(6). doi: 10.3892/ijo.2024.5648. Epub 2024 May 2.
5
Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study.
Neuropsychiatr Dis Treat. 2023 Jul 31;19:1711-1723. doi: 10.2147/NDT.S418381. eCollection 2023.
6
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications.
J Hematol Oncol. 2019 Jul 12;12(1):76. doi: 10.1186/s13045-019-0760-3.
7
Kallistatin suppresses cancer development by multi-factorial actions.
Crit Rev Oncol Hematol. 2017 May;113:71-78. doi: 10.1016/j.critrevonc.2017.03.011. Epub 2017 Mar 14.
8
Honokiol protects skin cells against inflammation, collagenolysis, apoptosis, and senescence caused by cigarette smoke damage.
Int J Dermatol. 2017 Jul;56(7):754-761. doi: 10.1111/ijd.13569. Epub 2017 Feb 22.
本文引用的文献
1
TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling.
Nat Commun. 2014 Sep 17;5:4944. doi: 10.1038/ncomms5944.
2
Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis.
Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15894-9. doi: 10.1073/pnas.1208324109. Epub 2012 Sep 11.
3
Mouse corneal lymphangiogenesis model.
Nat Protoc. 2011 Jun;6(6):817-26. doi: 10.1038/nprot.2011.359. Epub 2011 May 19.
4
Tumor angiogenesis and molecular targets for therapy.
Front Biosci (Landmark Ed). 2009 Jan 1;14(10):3962-73. doi: 10.2741/3504.
5
Tumor-derived lymphangiogenic factors and lymphatic metastasis.
Biomed Pharmacother. 2007 Oct;61(9):534-9. doi: 10.1016/j.biopha.2007.08.009. Epub 2007 Sep 14.
6
Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action.
Blood. 2006 May 1;107(9):3531-6. doi: 10.1182/blood-2005-06-2538. Epub 2006 Jan 19.
7
Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis.
Nat Rev Cancer. 2005 Sep;5(9):735-43. doi: 10.1038/nrc1693.
8
PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis.
Cancer Cell. 2004 Oct;6(4):333-45. doi: 10.1016/j.ccr.2004.08.034.
9
Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability.
Circ Res. 2004 Mar 19;94(5):664-70. doi: 10.1161/01.RES.0000118600.91698.BB. Epub 2004 Jan 22.
10
Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis.
J Exp Med. 1994 Jul 1;180(1):377-82. doi: 10.1084/jem.180.1.377.
Zotero 插件